Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Price

AMRXStock
$17.92+85.40%52W
Market Cap$6.24B
P/E76.54x
PEG Ratio
Div yield
Beta1.25

AMRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)8.48%
Price vs S&P 500 (4W)-8.28%
VGM Score56.91
P/E Ratio (Annual)76.54x

AMRX Earnings Surprise History

Q2 250.25est. 0.17
Q3 250.17est. 0.14
Q4 250.21est. 0.18
Q1 260.27est. 0.17
Q2 260.30est. 0.23

AMRX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.09
4.09
4.10
4.18

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock
CCB$17.92
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Amneal Pharmaceuticals, Inc. Class A Common Stock

Amneal Pharmaceuticals develops and manufactures pharmaceutical products across three segments: Affordable Medicines (generics and essential drugs), Specialty (branded pharmaceuticals for CNS and endocrine disorders), and AvKARE (government pharmaceutical distribution). Operating in the U.S., India, and Ireland, the company serves diverse market segments including cost-conscious patients, specialty therapy areas, and government agencies.